A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Clinical trial NCT05467176 · COMPLETED

Trial details

NCT number: NCT05467176
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2022-10-04
Primary completion: 2026-06-30
Enrollment: 999

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.